​

Funding Round

Post-IPO Equity - Corvus Pharmaceuticals

Post-IPO Equity - Corvus Pharmaceuticals

Investment Firm

Overview

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Announced Date

May 05, 2021

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

EcoR1 Capital

EcoR1 Capital

EcoR1 Capital is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

2

Investor Name
Participant InvestorRichard A Miller
Participant InvestorEcoR1 Capital

Round Details and Background

Corvus Pharmaceuticals raised $10000000 on 2021-05-05 in Post-IPO Equity

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 05, 2021
Post-IPO Equity - Corvus Pharmaceuticals
2-10.0M
May 02, 2024
Post-IPO Equity - Corvus Pharmaceuticals
7-30.6M
Sep 25, 2015
Series B - Corvus Pharmaceuticals
6-75.0M
Dec 01, 2014
Series A - Corvus Pharmaceuticals
1-33.5M

Recent Activity

There is no recent news or activity for this profile.